Table 1.
Patient age | Range | 24 – 88 |
Mean +/− sd | 58 +/− 14.4 | |
Median | 57 | |
| ||
AJCC Stage | Pre-neoadjuvant stage | Post-neoadjuvant stage |
|
||
0 | 0 | 14 |
I | 4 | 9 |
II | 17 | 12 |
A | 15 | 12 |
B | 2 | 0 |
C | 0 | 0 |
III | 23 | 12 |
A | 5 | 4 |
B | 18 | 8 |
C | 0 | 0 |
IV | 6 | 3 |
A | 6 | 3 |
B | 0 | 0 |
| ||
Time from last chemoradiotherapy to surgery (weeks) | Range | 3 – 110 |
Mean +/− sd | 16 +/− 23.3 | |
Median | 9 | |
| ||
Length of follow up (months) | Range | 2 – 264 |
Mean +/− sd | 50 +/− 60.2 | |
Median | 28 | |
| ||
Status at last follow up | ned* | 25 |
awd† | 23 | |
ddd‡ | 1 | |
du§ | 1 |
no evidence of disease
alive with disease
died due to disease
died unknown